However, Stryker’s overall net sales remained relatively flat (0.1 percent decrease) on a constant currency bias.
The company’s orthopedic implant sales increased 5.1 percent on a constant currency basis, and medical/surgical equipment sales decreased 7.7 percent on a constant currency basis.
Stryker anticipates an unfavorable impact on net sales of approximately 1.5-2.5 percent in the third quarter of 2009 and an unfavorable impact on net sales of approximately 2-3 percent for the full year of 2009, according to the release.
Read the release on Stryker’s Q2 earnings.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
